Confirm Rx insertable cardiac monitor for primary atrial fibrillation detection in high‐risk heart failure patients (Confirm‐AF trial)
Authors:
Open Access
- 27 November 2022
- journal article
- research article
- Published by Wiley in Annals of Noninvasive Electrocardiology
- Vol. 28 (1)
Abstract
Background: Patients with heart failure (HF) represent a large population of patients who are at high risk for complications related to undiagnosed atrial fibrillation (AF). However, currently there are limited modalities available for early AF detection in this high‐risk population. An implantable cardiac monitor (ICM) is inserted subcutaneously and can provide long‐term arrhythmia information via remote monitoring.Methods and Results: Confirm‐AF is a prospective randomized, nonblinded, two arm, multicenter clinical trial to be performed in the United States, enrolling 477 patients with a history of HF hospitalization and left ventricular ejection fraction >35% from 30 medical sites. Patients will be randomized in a 2:1 fashion to undergo ICM implant with remote monitoring and symptom‐triggered mobile app transmissions versus (vs.) Non‐ICM management and follow‐up. The primary objective of this trial is to compare the time to first detection of AF lasting > 5 min using an Abbott ICM compared to non‐ICM monitoring in symptomatic HF patients. This article describes the design and analytic plan for the Confirm‐AF trial.Conclusions: The Confirm‐AF trial seeks to accurately define the burden of AF in high‐risk HF patients with LVEF > 35% using an Abbott ICM. A finding showing significantly higher incidence of AF along with improved clinical outcomes with ICM monitoring is expected to have substantial clinical implications and may change the method of monitoring high‐risk HF patients.Keywords
Funding Information
- Abbott Laboratories
This publication has 21 references indexed in Scilit:
- Patient Selection in Heart Failure With Preserved Ejection Fraction Clinical TrialsJACC, 2015
- Epidemiology of Heart Failure with Preserved Ejection FractionHeart Failure Clinics, 2014
- Cryptogenic Stroke and Underlying Atrial FibrillationNew England Journal of Medicine, 2014
- Forecasting the Impact of Heart Failure in the United StatesCirculation: Heart Failure, 2013
- Presence of Atrial Fibrillation Is Independently Associated With Adverse Outcomes in Patients Hospitalized With Heart FailureCirculation: Heart Failure, 2012
- Atrial Fibrillation and Heart FailureCirculation, 2009
- Heart Failure Incidence and Survival (from the Atherosclerosis Risk in Communities Study)The American Journal of Cardiology, 2008
- Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programAmerican Heart Journal, 2006
- Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates 11Reprints are not available.The American Journal of Cardiology, 1998
- Stroke Severity in Atrial FibrillationStroke, 1996